173 related articles for article (PubMed ID: 23356912)
1. Utility of computed tomography fusion imaging for the evaluation of the ablative margin of radiofrequency ablation for hepatocellular carcinoma and the correlation to local tumor progression.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Ohama H; Matsumoto Y; Nakahara M; Zushi S; Kurokawa M; Isotani K; Takamura M; Fujita N; Murakami T
Hepatol Res; 2013 Sep; 43(9):950-8. PubMed ID: 23356912
[TBL] [Abstract][Full Text] [Related]
2. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.
Laimer G; Schullian P; Jaschke N; Putzer D; Eberle G; Alzaga A; Odisio B; Bale R
Eur Radiol; 2020 May; 30(5):2463-2472. PubMed ID: 32002642
[TBL] [Abstract][Full Text] [Related]
3. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Local Tumor Progression after Radiofrequency Ablation (RFA) of Hepatocellular Carcinoma by Assessment of Ablative Margin Using Pre-RFA MRI and Post-RFA CT Registration.
Yoon JH; Lee JM; Klotz E; Woo H; Yu MH; Joo I; Lee ES; Han JK
Korean J Radiol; 2018; 19(6):1053-1065. PubMed ID: 30386137
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images.
Takeyama N; Mizobuchi N; Sakaki M; Shimozuma Y; Munechika J; Kajiwara A; Uchikoshi M; Uozumi S; Ohgiya Y; Gokan T
Abdom Radiol (NY); 2019 Mar; 44(3):923-935. PubMed ID: 30327828
[TBL] [Abstract][Full Text] [Related]
7. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
8. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
9. Insufficient ablative margin determined by early computed tomography may predict the recurrence of hepatocellular carcinoma after radiofrequency ablation.
Teng W; Liu KW; Lin CC; Jeng WJ; Chen WT; Sheen IS; Lin CY; Lin SM
Liver Cancer; 2015 Mar; 4(1):26-38. PubMed ID: 26020027
[TBL] [Abstract][Full Text] [Related]
10. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of Extracted-Overlay Fusion Imaging for Intraoperative Treatment Evaluation of Radiofrequency Ablation for Hepatocellular Carcinoma.
Makino Y; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Iwamoto T; Okabe J; Takamura M; Fujita N; Hori M; Takehara T; Kudo M; Murakami T
Liver Cancer; 2016 Oct; 5(4):269-279. PubMed ID: 27781199
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional contrast-enhanced ultrasound fusion imaging predicts local tumor progression by evaluating ablative margin of radiofrequency ablation for hepatocellular carcinoma: a preliminary report.
Ye J; Huang G; Zhang X; Xu M; Zhou X; Lin M; Xie X; Xie X
Int J Hyperthermia; 2019; 36(1):55-64. PubMed ID: 30444428
[TBL] [Abstract][Full Text] [Related]
13. A feasibility study: evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT.
Fujioka C; Horiguchi J; Ishifuro M; Kakizawa H; Kiguchi M; Matsuura N; Hieda M; Tachikake T; Alam F; Furukawa T; Ito K
Acad Radiol; 2006 Aug; 13(8):986-94. PubMed ID: 16843851
[TBL] [Abstract][Full Text] [Related]
14. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma.
Wang XL; Li K; Su ZZ; Huang ZP; Wang P; Zheng RQ
World J Gastroenterol; 2015 May; 21(17):5345-51. PubMed ID: 25954109
[TBL] [Abstract][Full Text] [Related]
15. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
[TBL] [Abstract][Full Text] [Related]
16. Postablation assessment using follow-up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma.
Shin S; Lee JM; Kim KW; Joo I; Han JK; Choi BI; Klotz E
AJR Am J Roentgenol; 2014 Jul; 203(1):70-7. PubMed ID: 24951197
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma.
Tomonari A; Tsuji K; Yamazaki H; Aoki H; Kang JH; Kodama Y; Sakurai Y; Maguchi H
Hepatol Res; 2013 Jul; 43(7):728-34. PubMed ID: 23198863
[TBL] [Abstract][Full Text] [Related]
18. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration.
Minami Y; Minami T; Ueshima K; Yagyu Y; Tsurusaki M; Okada T; Hori M; Kudo M; Murakami T
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33806751
[TBL] [Abstract][Full Text] [Related]
19. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance.
Park Y; Choi D; Rhim H; Kim YS; Lee JY; Chang I; Lim HK; Park CK
Eur J Radiol; 2010 Sep; 75(3):391-6. PubMed ID: 19467813
[TBL] [Abstract][Full Text] [Related]
20. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]